Gene · 2923
Papers3,219
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,219
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advancements in CRISPR screens for the development of cancer immunotherapy strategies. | Mol Ther Oncolytics | 2023 | 37876793 | PubTator, text mining | PubMed |
| Development of an immunogenic cell death prognostic signature for predicting clinical outcome and immune infiltration characterization in stomach adenocarcinoma. | Aging (Albany NY) | 2023 | 37862109 | PubTator, text mining | PubMed |
| In silico prediction of deleterious non-synonymous SNPs in STAT3. | Asian Biomed (Res Rev News) | 2023 | 37860678 | PubTator, text mining | PubMed |
| The vitamin D receptor agonist EB1089 can exert its antiviral activity independently of the vitamin D receptor. | PLoS One | 2023 | 37847693 | PubTator, text mining | PubMed |
| Integration of bioinformatics and machine learning strategies identifies APM-related gene signatures to predict clinical outcomes and therapeutic responses for breast cancer patients. | Neoplasia | 2023 | 37839160 | PubTator, text mining | PubMed |
| Extracellular vesicles in hematological malignancies: EV-dence for reshaping the tumoral microenvironment. | Front Immunol | 2023 | 37822925 | PubTator, text mining | PubMed |
| Functional filter for whole-genome sequencing data identifies HHT and stress-associated non-coding SMAD4 polyadenylation site variants >5 kb from coding DNA. | Am J Hum Genet | 2023 | 37816352 | PubTator, text mining | PubMed |
| NRF3 suppresses squamous carcinogenesis, involving the unfolded protein response regulator HSPA5. | EMBO Mol Med | 2023 | 37807968 | PubTator, text mining | PubMed |
| Construction of a novel disulfidptosis-related signature for improving outcomes in hepatocellular carcinoma: Observational study. | Medicine (Baltimore) | 2023 | 37800779 | PubTator, text mining | PubMed |
| Neuronal MHC-I complex is destabilized by amyloid-β and its implications in Alzheimer's disease. | Cell Biosci | 2023 | 37773139 | PubTator, text mining | PubMed |
| Monomeric agonist peptide/MHCII complexes activate T-cells in an autonomous fashion. | EMBO Rep | 2023 | 37768718 | PubTator, text mining | PubMed |
| Role of heat shock protein 47 in platelet glycoprotein VI dimerization and signaling. | Res Pract Thromb Haemost | 2023 | 37767064 | PubTator, text mining | PubMed |
| Introducing Molecular Chaperones into the Causality and Prospective Management of Autoimmune Hepatitis. | Dig Dis Sci | 2023 | 37755606 | PubTator, text mining | PubMed |
| Reovirus infection of tumor cells reduces the expression of NKG2D ligands, leading to impaired NK-cell cytotoxicity and functionality. | Front Immunol | 2023 | 37753084 | PubTator, text mining | PubMed |
| Updates on ankylosing spondylitis: pathogenesis and therapeutic agents. | J Rheum Dis | 2023 | 37736590 | PubTator, text mining | PubMed |
| Proteome-wide mendelian randomization study implicates therapeutic targets in common cancers. | J Transl Med | 2023 | 37735436 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing Reveals That Adaptation of Human Aortic Endothelial Cells to Antiproliferative Therapies Is Modulated by Flow-Induced Shear Stress. | Arterioscler Thromb Vasc Biol | 2023 | 37732484 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis uncovers underlying mechanisms of acute liver injury induced by tripterygium glycosides tablet in mice. | J Pharm Anal | 2023 | 37719192 | PubTator, text mining | PubMed |
| Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironment. | Nat Commun | 2023 | 37714830 | PubTator, text mining | PubMed |
| The FDA-approved drug nitazoxanide is a potent inhibitor of human seasonal coronaviruses acting at postentry level: effect on the viral spike glycoprotein. | Front Microbiol | 2023 | 37705731 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2923/papers?page=11